PORT WASHINGTON, N.Y., Aug. 23, 2012 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sales and distribution of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals, today announced that it will issue its financial results of operations for its 2012 fiscal fourth quarter and year ended June 30, 2012 after the stock market closes on Thursday, September 6, 2012. On Friday, September 7, 2012, at 9:00 am ET, Albert Eilender, Salvatore Guccione, Ronald Gold and Douglas Roth will conduct a conference call. Interested parties may participate in the call by dialing 800-447-0521 (847-413-3238 for international callers) – please call in 10 minutes before the call is scheduled to begin, and ask for the ACETO call (conference ID # 33144305). The conference call will also be webcast live via the Investor Relations section of our website, www.aceto.com . To listen to the live call please go to the website at least 15 minutes early to register, download and install any necessary audio software. The conference call will be archived on the Company's website, and a recorded phone replay will also be available from 1:00 p.m. ET on Friday, September 7, 2012 until 5:00 p.m. ET on Monday, September 10, 2012. Dial 888-843-7419 (630-652-3042 for international callers) and enter the code 33144305 for the phone replay. ABOUT ACETO ACETO Corporation, incorporated in 1947, is a global leader in the marketing, sales and distribution of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals. With business operations in nine countries, ACETO distributes over 1,100 chemical compounds used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical consuming industries. ACETO's global operations, including a staff of 26 in China and 12 in India are distinctive in the industry and enable its worldwide sourcing and regulatory capabilities.